Investors File Class Action Against Nano-X Imaging Over Misleading Claims

The complaint centers on claims that Nano-X management provided false assessments regarding product demand and operational gains. According to the filing, the company failed to disclose that its production capabilities were poorly aligned with market needs, leading to unsustainable cash burn and inflated operating expenses. This misalignment ultimately forced the company to undergo a significant restructuring of its Korean chip manufacturing facility.

The consequences of these internal issues became public on April 20, 2026, when Nano-X reported a $33.4 million net loss for the fourth quarter of 2025. This figure included a $17.5 million impairment charge tied to the manufacturing shift toward an outsourced production model. Following the disclosure of these financial setbacks and the concurrent announcement that CFO Ran Daniel would step down, the company's stock price plummeted 24.39%, closing at $2.155 per share.

Robbins LLP is currently seeking investors who held NNOX securities during the defined class period to act as lead plaintiffs. Participation in the litigation is on a contingency fee basis, meaning shareholders are not responsible for upfront costs. Those who prefer not to take active roles remain eligible for potential recovery as absent class members.